Displaying 1 - 50 of 322 results
Released Company Title Industry Topic
23 Nov 2021
17:45 CET
MEDIAN TECHNOLOGIES Median Technologies Announces New Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization 10101015 Software Meetings / events
23 Nov 2021
17:45 CET
MEDIAN TECHNOLOGIES Median Technologies annonce de nouvelles performances exceptionnelles pour le diagnostic iBiopsy® (CADx1) LCS portant spécifiquement sur la caractérisation du cancer pulmonaire de stade 1 10101015 Software Meetings / events
08 Nov 2021
17:45 CET
MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2021 10101015 Software Legal
08 Nov 2021
17:45 CET
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 octobre 2021 10101015 Software Legal
21 Oct 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators 10101015 Software Income
21 Oct 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies communique ses résultats semestriels 2021 et son niveau d’activité pour le troisième trimestre 2021 10101015 Software Income
13 Oct 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies fera un point d’avancement par webcast le 25 octobre 2021 10101015 Software Meetings / events
13 Oct 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies to Host a Live Webcast and Provide a Company Update on October 25th, 2021 10101015 Software Meetings / events
06 Oct 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 septembre 2021 10101015 Software Corporate life
06 Oct 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30th, 2021 10101015 Software Corporate life
16 Sep 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications 10101015 Software News contracts
16 Sep 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies a été confirmé comme fournisseur privilégié d’un des laboratoires pharmaceutiques membre du Top 3 au niveau mondial 10101015 Software News contracts
14 Sep 2021
08:30 CEST
MEDIAN TECHNOLOGIES Median Technologies Changes the Publication Date of Its H1 2021 Results 10101015 Software Meetings / events
14 Sep 2021
08:30 CEST
MEDIAN TECHNOLOGIES Median Technologies modifie la date de publication de ses résultats semestriels 10101015 Software Meetings / events
08 Sep 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2021 10101015 Software Corporate life
08 Sep 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 août 2021 10101015 Software Corporate life
06 Sep 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies annonce des performances exceptionnelles pour le diagnostic iBiopsy® (CADx1), permettant de caractériser les nodules pulmonaires malins et bénins dans le cadre d’un dépistage du cancer du poumon 10101015 Software New
06 Sep 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies Announces Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 to Accurately Characterize Malignant vs Benign Lung Nodules Based on a Large-scale Patient Cohort 10101015 Software New
05 Aug 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 juillet 2021 10101015 Software Other subject
05 Aug 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2021 10101015 Software Other subject
29 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies Appoints Jean-Christophe Montigny as Chief Financial Officer and Member of the Executive Committee 10101015 Software Journal / appointments
29 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies nomme Jean-Christophe Montigny en tant que Chief Financial Officer et membre du comité exécutif 10101015 Software Journal / appointments
13 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Bilan semestriel du contrat de liquidité Median Technologies contracté avec la société TP ICAP (Europe) 10101015 Software Legal
13 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Half Year Median Technologies Liquidity Contract Statement Contracted With TP ICAP (Europe) 10101015 Software Legal
09 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Calendrier de communication financière du second semestre 2021 10101015 Software Legal
09 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies: Financial Communication Schedule for the Second Half Of 2021 10101015 Software Legal
08 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES La croissance de l’activité de Median Technologies se poursuit à un rythme soutenu au premier semestre 2021 (chiffres non audités) 10101015 Software Commercial results
08 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies' Business Continues to Grow at a Steady Pace in the First Half of 2021 (Unaudited Figures) 10101015 Software Commercial results
05 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30th, 2021 10101015 Software Other subject
05 Jul 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 juin 2021 10101015 Software Other subject
07 Jun 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31st, 2021 10101015 Software Other subject
07 Jun 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 mai 2021 10101015 Software Other subject
07 May 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2021 10101015 Software Other subject
07 May 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 avril 2021 10101015 Software Other subject
13 Apr 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2021 10101015 Software Other subject
13 Apr 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 mars 2021 10101015 Software Other subject
08 Apr 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies Is Releasing Full Year 2020 Financial Results (audited) as Well as Q1 2021 Business Activity Indicators, Showing a Very Strong Growth 10101015 Software Other subject
08 Apr 2021
17:45 CEST
MEDIAN TECHNOLOGIES Median Technologies communique ses résultats annuels 2020 audités ainsi que son niveau d’activité pour le premier trimestre 2021 montrant une accélération très forte de la croissance 10101015 Software Other subject
25 Mar 2021
08:00 CET
MEDIAN TECHNOLOGIES Median Technologies: Highly Successful Capital Increase via a Private Placement of 28.1 Million Euros 10101015 Software Other subject
25 Mar 2021
08:00 CET
MEDIAN TECHNOLOGIES Median Technologies : très vif succès de l’augmentation de capital par placement privé d’un montant de 28,1 millions d’euros 10101015 Software Other subject
24 Mar 2021
17:40 CET
MEDIAN TECHNOLOGIES Median Technologies Launches a Capital Increase via a Private Placement 10101015 Software Other subject
24 Mar 2021
17:40 CET
MEDIAN TECHNOLOGIES Median Technologies lance une augmentation de capital par placement privé 10101015 Software Other subject
04 Mar 2021
17:45 CET
MEDIAN TECHNOLOGIES Median Technologies répond aux conditions d’éligibilité du dispositif PEA-PME 10101015 Software Other subject
03 Mar 2021
17:45 CET
MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 28 février 2021 10101015 Software Other subject
03 Mar 2021
17:45 CET
MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28th, 2021 10101015 Software Other subject
01 Mar 2021
08:00 CET
MEDIAN TECHNOLOGIES Median Technologies fera un point d’avancement par webcast le 9 mars 2021 10101015 Software Other subject
01 Mar 2021
08:00 CET
MEDIAN TECHNOLOGIES Median Technologies to Host a Live Webcast and Provide a Company Update on March 9th, 2021 10101015 Software Other subject
25 Feb 2021
17:45 CET
MEDIAN TECHNOLOGIES Median Strengthens its iBiopsy® Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty as Sr. Strategy Advisor, Product Development 10101015 Software Journal / appointments
25 Feb 2021
17:45 CET
MEDIAN TECHNOLOGIES Median renforce son équipe de management iBiopsy® avec la nomination de Thomas Bonnefont comme Chief Operating and Commercial Officer et celle de Mike Doherty comme Sr. Strategy Advisor, Product Development 10101015 Software Journal / appointments
16 Feb 2021
17:45 CET
MEDIAN TECHNOLOGIES iBiopsy®: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS) 10101015 Software New